Literature DB >> 12956189

Variations in skin dose using 6MV or 18MV x-ray beams.

P K N Yu1, T Cheung, M J Butson.   

Abstract

This research aimed to quantitatively evaluate the differences in percentage dose of maximum for 6MV and 18MV x-ray beams within the first 1 cm of interactions. Thus provide quantitative information regarding the basal, dermal and subcutaneous dose differences achievable with these two types of high-energy x-ray beams. Percentage dose of maximum build up curves are measured for most clinical field sizes using 6MV and 18MV x-ray beams. Calculations are performed to produce quantitative results highlighting the percentage dose of maximum differences delivered to various depths within the skin and subcutaneous tissue region by these two beams. Results have shown that basal cell layer doses are not significantly different for 6MV and 18MV x-ray beams. At depths beyond the surface and basal cell layer there is a measurable and significant difference in delivered dose. This variation increases to 20% of maximum and 22% of maximum at 1 mm and 1 cm depths respectively. The percentage variations are larger for smaller field sizes where the photon in phantom component of the delivered dose is the most significant contributor to dose. By producing graphs or tables of % dose differences in the build up region we can provide quantitative information to the oncologist for consideration (if skin and subcutaneous tissue doses are of importance) during the beam energy selection process for treatment.

Mesh:

Year:  2003        PMID: 12956189

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  2 in total

1.  Build-up material requirements in clinical dosimetry during total body irradiation treatments.

Authors:  Martin Butson; Dane Pope; Mamoon Haque; Tom Chen; Guangli Song; May Whitaker
Journal:  J Med Phys       Date:  2016 Apr-Jun

2.  Skin dose during radiotherapy: a summary and general estimation technique.

Authors:  Stephen F Kry; Susan A Smith; Rita Weathers; Marilyn Stovall
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.